Table 3.
Serum expression of miR‐145, miR‐185, miR‐381, and miR‐195 in patients with GC before neoadjuvant chemotherapy with different treatment outcomes
| miR‐145 | miR‐185 | miR‐381 | miR‐195 | |
|---|---|---|---|---|
| CR (6) | 0.6655 ± 0.0732 | 0.4249 ± 0.0647 | 0.3817 ± 0.1067 | 0.2295 ± 0.1297 |
| PR (51) | 0.5097 ± 0.0671 | 0.2863 ± 0.1187 | 0.4627 ± 0.1882 | 0.2598 ± 0.1064 |
| SD (44) | 0.3350 ± 0.1656 | 0.1952 ± 0.0981 | 0.5566 ± 0.1889 | 0.2466 ± 0.1023 |
| PD (19) | 0.2579 ± 0.0547 | 0.1247 ± 0.032 | 0.4158 ± 0.2029 | 0.2863 ± 0.0908 |
| F | 41.2185 | 21.7502 | 3.8211 | 0.8014 |
| P | <.001 | <.001 | .0118 | .4937 |